Loading clinical trials...
Loading clinical trials...
A Retrospective Observational Clinical Study on the Use of Continuous Glucose Monitoring for Glycemic Control in Adult and Pediatric Patients With Glycogen Storage Disease Type Ia (GSDIa)
Conditions
Interventions
No Intervention
Locations
2
United States
UT Health - McGovern Medical School
Houston, Texas, United States
University Medical Center Groningen
Groningen, Netherlands
Start Date
November 5, 2020
Primary Completion Date
March 4, 2022
Completion Date
March 4, 2022
Last Updated
May 29, 2024
NCT06843330
NCT03970278
NCT02054832
Lead Sponsor
Ultragenyx Pharmaceutical Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions